Should Suicide of the VA Health Care System Be Condoned?

If the Veterans Administration (VA) health care system could be kept from becoming the world's worst health maintenance organization (HMO), could it serve as an expanded Public Health Service? A number of ominous signs suggest that the VA health care system may not exist much longer. Its aging patient population, 50 percent of whom are World War II and Korean War veterans, will never be replaced, because nuclear weapons have made large standing armies obsolete. And the 90 percent of Vietnam-er

Written byDavid Moskowitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

If the Veterans Administration (VA) health care system could be kept from becoming the world's worst health maintenance organization (HMO), could it serve as an expanded Public Health Service?

A number of ominous signs suggest that the VA health care system may not exist much longer. Its aging patient population, 50 percent of whom are World War II and Korean War veterans, will never be replaced, because nuclear weapons have made large standing armies obsolete. And the 90 percent of Vietnam-era veterans who don't use the VA now because they have private health insurance will not need the VA in the future, because they will soon qualify for Medicare.

It is not clear what the magic number of patients is, below which the VA's vast infrastructure of 173 medical centers and more than 300 satellite clinics and nursing homes becomes too expensive. But it is likely that hospitals will be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies